AI-assisted, human-published
04/23/2026 /Funding Events
Ray Therapeutics Raises $125M in Series B Financing for Vision Restoration Therapies
Ray Therapeutics, also known as RayTx, concludes an oversubscribed $125 million Series B financing round led by Janus Henderson Investors, focusing on developing optogenetic therapies for restoring vision in patients with retinal degenerative diseases.
AI-assisted, human-published
Latest headlines
-
-
-
Stay connected!
If you have a serious, bonafide inquiry into the VentureCapital.com or PrivateEquity.com domain names, please contact us here
©2023 VentureCapital.com